Delivery Order SPE2DE23D0008-SPE2D625F4BNR
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,495.00 on September 2, 2025, for the supply of Natrelle TE Smooth 133S-MX-13-T breast implants. This fixed-price contract with economic price adjustment is funded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical and is scheduled for completion by September 4, 2025. The contract carries no set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,404.00 for Natrelle TE Smooth 133S-MX-14-T breast implants on July 24, 2025. This delivery order, issued without set-aside designation, represents a child contract under Allergan's larger Indefinite Delivery Vehicle (IDV) agreements with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is funded through the Medical Supply Chain division of DLA and involves fixed-price...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 10, 2025, for Natrelle TE Smooth 133S breast implants. This delivery order, which carries an ultimate completion date of July 28, 2025, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical on December 8, 2022. The award was made without...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $1,495 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical for NATRELLE TE SMOOTH 133S-MX-14-T breast implants. The contract has no set-aside designation and calls for Allergan to provide the proprietary breast implants for reconstructive procedures, with performance taking place at Allergan's Irvine, California facility. Allergan additionally maintains several vehicles with the Agency, including a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $3,021.00 for Natrelle Inspira SCLP 300cc breast implants from the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which carries no set-aside designation, was awarded on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed at Allergan's facility in Irvine, California. The award reflects Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical for NATRELLE TE SMOOTH 133S-FX-13-T breast implants. Performance will occur at Allergan's facility in Irvine, California, with no set-aside designation applied. As the sole-source provider of the proprietary implant products, Allergan will deliver the devices and provide on-site expertise for proper clinical use supporting breast...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F4BNRDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-14-T breast implants under a fixed-price contract with economic price adjustment. The award was issued on September 11, 2025, with an ultimate completion date of September 25, 2025, and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The product will be delivered to Irvine, California, with funding provided by the Defense Logistics Agency's Medical Supply Chain division, which manages medical supply procurement for Department of Defense facilities. This delivery order is issued under Allergan's larger Indefinite Delivery Vehicle contract worth $13.5 million for Natrelle breast implants and surgical devices, established on December 8, 2022, with the Defense Logistics Agency Troop Support Medical. The IDV structure enables electronic ordering and fulfillment of Allergan's products across Department of Defense research centers, hospitals, and clinics, providing critical reconstructive and aesthetic surgical supplies to military members and veterans. The fixed-price contract with economic price adjustment framework ensures cost stability while allowing for adjustments based on economic factors, supporting the continuity of specialized surgical capabilities across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/11/25 |